United States Interferon Alpha-2b Biosimilar Market Report 2017

August 2017 | 97 pages | ID: U3DA243DC50EN
QYResearch

Abstracts

In this report, the United States Interferon Alpha-2b Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Interferon Alpha-2b Biosimilar in these regions, from 2012 to 2022 (forecast).

United States Interferon Alpha-2b Biosimilar market competition by top manufacturers/players, with Interferon Alpha-2b Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer
• Novartis
• Sanofi
• Roche
• Pfizer
• Merck
• Medarex
• Eisai Co
• Amgen

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Interferon Alpha-2b Biosimilar for each application, including

• Application 1
• Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Interferon Alpha-2b Biosimilar Market Report 2017

1 INTERFERON ALPHA-2B BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Interferon Alpha-2b Biosimilar
1.2 Classification of Interferon Alpha-2b Biosimilar by Product Category
  1.2.1 United States Interferon Alpha-2b Biosimilar Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Interferon Alpha-2b Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3
  1.2.4
1.3 United States Interferon Alpha-2b Biosimilar Market by Application/End Users
  1.3.1 United States Interferon Alpha-2b Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.1 Application
  1.3.2 Application
1.4 United States Interferon Alpha-2b Biosimilar Market by Region
  1.4.1 United States Interferon Alpha-2b Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Interferon Alpha-2b Biosimilar Status and Prospect (2012-2022)
  1.4.3 Southwest Interferon Alpha-2b Biosimilar Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Interferon Alpha-2b Biosimilar Status and Prospect (2012-2022)
  1.4.5 New England Interferon Alpha-2b Biosimilar Status and Prospect (2012-2022)
  1.4.6 The South Interferon Alpha-2b Biosimilar Status and Prospect (2012-2022)
  1.4.7 The Midwest Interferon Alpha-2b Biosimilar Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Interferon Alpha-2b Biosimilar (2012-2022)
  1.5.1 United States Interferon Alpha-2b Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 United States Interferon Alpha-2b Biosimilar Revenue and Growth Rate (2012-2022)

2 UNITED STATES INTERFERON ALPHA-2B BIOSIMILAR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Interferon Alpha-2b Biosimilar Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Interferon Alpha-2b Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Interferon Alpha-2b Biosimilar Average Price by Players/Suppliers (2012-2017)
2.4 United States Interferon Alpha-2b Biosimilar Market Competitive Situation and Trends
  2.4.1 United States Interferon Alpha-2b Biosimilar Market Concentration Rate
  2.4.2 United States Interferon Alpha-2b Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Interferon Alpha-2b Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTERFERON ALPHA-2B BIOSIMILAR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Interferon Alpha-2b Biosimilar Sales and Market Share by Region (2012-2017)
3.2 United States Interferon Alpha-2b Biosimilar Revenue and Market Share by Region (2012-2017)
3.3 United States Interferon Alpha-2b Biosimilar Price by Region (2012-2017)

4 UNITED STATES INTERFERON ALPHA-2B BIOSIMILAR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Interferon Alpha-2b Biosimilar Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Interferon Alpha-2b Biosimilar Revenue and Market Share by Type (2012-2017)
4.3 United States Interferon Alpha-2b Biosimilar Price by Type (2012-2017)
4.4 United States Interferon Alpha-2b Biosimilar Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INTERFERON ALPHA-2B BIOSIMILAR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Interferon Alpha-2b Biosimilar Sales and Market Share by Application (2012-2017)
5.2 United States Interferon Alpha-2b Biosimilar Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTERFERON ALPHA-2B BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck
  6.6.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Medarex
  6.7.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Medarex Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eisai Co
  6.8.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eisai Co Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amgen
  6.9.2 Interferon Alpha-2b Biosimilar Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Interferon Alpha-2b Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 INTERFERON ALPHA-2B BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Interferon Alpha-2b Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Interferon Alpha-2b Biosimilar

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Interferon Alpha-2b Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Interferon Alpha-2b Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTERFERON ALPHA-2B BIOSIMILAR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Interferon Alpha-2b Biosimilar Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Interferon Alpha-2b Biosimilar Sales Volume Forecast by Type (2017-2022)
11.3 United States Interferon Alpha-2b Biosimilar Sales Volume Forecast by Application (2017-2022)
11.4 United States Interferon Alpha-2b Biosimilar Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Interferon Alpha-2b Biosimilar
Figure United States Interferon Alpha-2b Biosimilar Market Size (K Units) by Type (2012-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure United States Interferon Alpha-2b Biosimilar Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Interferon Alpha-2b Biosimilar by Application in 2016
Table Key Downstream Customer in Application
Table Key Downstream Customer in Application
Figure United States Interferon Alpha-2b Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure The West Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales (K Units) and Growth Rate (2012-2022)
Figure United States Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Interferon Alpha-2b Biosimilar Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Interferon Alpha-2b Biosimilar Sales Share by Players/Suppliers
Figure 2017 United States Interferon Alpha-2b Biosimilar Sales Share by Players/Suppliers
Figure United States Interferon Alpha-2b Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Interferon Alpha-2b Biosimilar Revenue Share by Players/Suppliers
Figure 2017 United States Interferon Alpha-2b Biosimilar Revenue Share by Players/Suppliers
Table United States Market Interferon Alpha-2b Biosimilar Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Interferon Alpha-2b Biosimilar Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Interferon Alpha-2b Biosimilar Market Share of Top 3 Players/Suppliers
Figure United States Interferon Alpha-2b Biosimilar Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Interferon Alpha-2b Biosimilar Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Interferon Alpha-2b Biosimilar Product Category
Table United States Interferon Alpha-2b Biosimilar Sales (K Units) by Region (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales Share by Region (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Share by Region (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Market Share by Region in 2016
Table United States Interferon Alpha-2b Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Revenue Share by Region (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Revenue Market Share by Region (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Revenue Market Share by Region in 2016
Table United States Interferon Alpha-2b Biosimilar Price (USD/Unit) by Region (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales (K Units) by Type (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales Share by Type (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Share by Type (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Market Share by Type in 2016
Table United States Interferon Alpha-2b Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Interferon Alpha-2b Biosimilar by Type (2012-2017)
Figure Revenue Market Share of Interferon Alpha-2b Biosimilar by Type in 2016
Table United States Interferon Alpha-2b Biosimilar Price (USD/Unit) by Types (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Growth Rate by Type (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales (K Units) by Application (2012-2017)
Table United States Interferon Alpha-2b Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Market Share by Application in 2016
Table United States Interferon Alpha-2b Biosimilar Sales Growth Rate by Application (2012-2017)
Figure United States Interferon Alpha-2b Biosimilar Sales Growth Rate by Application (2012-2017)
Table Bayer Basic Information List
Table Bayer Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Bayer Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Bayer Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Novartis Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Novartis Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Sanofi Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Sanofi Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Roche Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Roche Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Pfizer Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Pfizer Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Merck Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Merck Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Medarex Basic Information List
Table Medarex Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medarex Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Medarex Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Medarex Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Eisai Co Basic Information List
Table Eisai Co Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eisai Co Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Eisai Co Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Eisai Co Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Interferon Alpha-2b Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Interferon Alpha-2b Biosimilar Sales Growth Rate (2012-2017)
Figure Amgen Interferon Alpha-2b Biosimilar Sales Market Share in United States (2012-2017)
Figure Amgen Interferon Alpha-2b Biosimilar Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Interferon Alpha-2b Biosimilar
Figure Manufacturing Process Analysis of Interferon Alpha-2b Biosimilar
Figure Interferon Alpha-2b Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Interferon Alpha-2b Biosimilar Major Players/Suppliers in 2016
Table Major Buyers of Interferon Alpha-2b Biosimilar
Table Distributors/Traders List
Figure United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Type in 2022
Table United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Application in 2022
Table United States Interferon Alpha-2b Biosimilar Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Interferon Alpha-2b Biosimilar Sales Volume Share Forecast by Region (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume Share Forecast by Region (2017-2022)
Figure United States Interferon Alpha-2b Biosimilar Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources